Search All UT System Experts

Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells

Brent N. Rexer, Siprachanh Chanthaphaychith, Kimberly B. Dahlman, Carlos L. Arteaga

Research output: Contribution to journal › Article › peer-review

62 Scopus citations

Fingerprint

Dive into the research topics of 'Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences